Analysis of immune responses in patients with CLL after heterologous COVID-19 vaccination

Patients with chronic lymphocytic leukemia (CLL) treated with B-cell pathway inhibitors and anti-CD20 antibodies exhibit low humoral response rates following SARS-CoV-2 vaccination. To investigate this observation, a prospective single-institution study was conducted comparing peripheral blood monon...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Hye Kyung, Hoechstetter, Manuela A., Buchner, Maike, Pham, Trang Thu, Huh, Jin Won, Müller, Katharina, Zange, Sabine, von Buttlar, Heiner, Girl, Philipp, Wölfel, Roman, Brandmeier, Lisa, Pfeuffer, Lisa, Furth, Priscilla A., Wendtner, Clemens-Martin, Hennighausen, Lothar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The American Society of Hematology 2023
Materias:
Immunobiology and Immunotherapy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9906673/
https://www.ncbi.nlm.nih.gov/pubmed/36630562
http://dx.doi.org/10.1182/bloodadvances.2022008445

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9906673/
https://www.ncbi.nlm.nih.gov/pubmed/36630562
http://dx.doi.org/10.1182/bloodadvances.2022008445

Ejemplares similares